Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients With Pulmonary P. Aeruginosa Requiring Frequent Antibiotics (AIR-CF2)
Brief Summary: The purpose of this study was to evaluate the safety and efficacy of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: MP-376 120 mg QD; Type: EXPERIMENTAL; Interventions: Drug: MP-376 | Arm Label: MP-376 240 mg QD; Type: EXPERIMENTAL; Interventions: Drug: MP-376 | Arm Label: MP-376 240 mg BID; Type: EXPERIMENTAL; Interventions: Drug: MP-376 | Intervention Type: DRUG; Name: MP-376; Assigned to Arm(s): MP-376 120 mg QD, MP-376 240 mg BID, MP-376 240 mg QD | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Rifampin, Drug: Trimethoprim/Sulfamethoxazole, Drug: Minocycline, Drug: Mupirocin, Drug: chlorhexidine gluconate oral rinse, Drug: 2% Chlorhexidine solution wipes, Behavioral: Environmental Decontamination | Arm Label: Observational; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Rifampin; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Trimethoprim/Sulfamethoxazole; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Minocycline; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Mupirocin; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: chlorhexidine gluconate oral rinse; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: 2% Chlorhexidine solution wipes; Assigned to Arm(s): Treatment | Intervention Type: BEHAVIORAL; Name: Environmental Decontamination; Assigned to Arm(s): Treatment
C: Arm Label: Inhaled Vanc and Oral Abx; Type: EXPERIMENTAL; Interventions: Drug: Inhaled Vancomycin, Drug: Rifampin, Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX), Drug: Doxycycline, Drug: Mupirocin Intranasal Creme, Drug: 4% chlorhexidine gluconate liquid skin cleanser | Arm Label: Inhaled Placebo and Oral Abx; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo (Sterile Water), Drug: Rifampin, Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX), Drug: Doxycycline, Drug: Mupirocin Intranasal Creme, Drug: 4% chlorhexidine gluconate liquid skin cleanser | Intervention Type: DRUG; Name: Inhaled Vancomycin; Assigned to Arm(s): Inhaled Vanc and Oral Abx | Intervention Type: DRUG; Name: Placebo (Sterile Water); Assigned to Arm(s): Inhaled Placebo and Oral Abx | Intervention Type: DRUG; Name: Rifampin; Assigned to Arm(s): Inhaled Placebo and Oral Abx, Inhaled Vanc and Oral Abx | Intervention Type: DRUG; Name: Trimethoprim/Sulfamethoxazole (TMP/SMX); Assigned to Arm(s): Inhaled Placebo and Oral Abx, Inhaled Vanc and Oral Abx | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Inhaled Placebo and Oral Abx, Inhaled Vanc and Oral Abx | Intervention Type: DRUG; Name: Mupirocin Intranasal Creme; Assigned to Arm(s): Inhaled Placebo and Oral Abx, Inhaled Vanc and Oral Abx | Intervention Type: DRUG; Name: 4% chlorhexidine gluconate liquid skin cleanser; Assigned to Arm(s): Inhaled Placebo and Oral Abx, Inhaled Vanc and Oral Abx
D: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])

Answer: D